Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, today announced new translational biomarker results for exploratory endpoints from its SER-155 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback